Inverventional Cardiology

Current Cardiology Reports

, Volume 9, Issue 5, pp 396-405

First online:

Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia

  • E. Marc Jolicoeur
  • , Tracy Wang
  • , Renato D. Lopes
  • , E. Magnus OhmanAffiliated withDuke Clinical Research Institute, Duke University Medical Center Email author 

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Accomplishing a successful percutaneous coronary intervention in a patient with a suspected or diagnosed heparin-induced thrombocytopenia (HIT) requires the selection of an appropriate alternative anticoagulant and a thorough assessment of bleeding and thrombotic risks. In this review, we suggest an evidence-based management algorithm that takes into account the clinical phase of HIT (acute, recent, and remote HIT) and the associated risk when patients present with acute coronary syndrome. The algorithm also integrates preventive measures directed at decreasing the bleeding risk associated with the antithrombotic and invasive therapies used for HIT and percutaneous coronary intervention.